2 September 2021 - The agenda for the November 2021 PBAC meeting has been updated. 

A summary of changes to the agenda is provided at the end of the agenda document.

This version (officially version 5 but really version 7) notes the addition of two early re-entry resubmissions:

• Budesonide (Jorveza)
• Siltuximab (Sylvant)

Read PBAC agenda